SuperworthEmbecta market cap EMBC
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $380.2M
- Highest close in our data
- $2B
- Nov 2022
Embecta is worth $380.2M at the close on Oct 23, 2026, at $6.71 a share.
That is down 55% over the last year.
Its highest close in our data was $2B in Nov 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $380.2M | $183.9M | $746.6M | −46% |
| 2025 | $702.7M | $558.7M | $1.2B | −42% |
| 2024 | $1.2B | $584.4M | $1.2B | +11% |
| 2023 | $1.1B | $805.7M | $1.8B | −25% |
| 2022 | $1.4B | $1.4B | $2B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Embecta's size, closest first, today.
| Company | Market cap |
|---|---|
| EMBCEmbecta | $380.2M |
| INFUInfuSystem | $277.6M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| UTMDUtah Medical Products | $236.3M |
| MOVMovado | $701.9M |
| PDEXPro DEX | $199.3M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| BVSBioventus | $1.3B |
| CDRECadre | $1.3B |
| Peer median | $635.9M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Embecta
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.